Epidemiological studies on radiation carcinogenesis in human populations following acute exposure: nuclear explosions and medical radiation. by Fabrikant, J. I.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 457-469
Epidemiological Studies on Radiation Carcinogenesis
in Human Populations Following Acute Exposure:
Nuclear Explosions and Medical Radiation*
JACOB I. FABRIKANT, M.D., Ph.D.**
Donner Laboratory, University ofCalifornia, Berkeley, and
Department ofRadiology, University of California School ofMedicine,
San Francisco, California
Received July 7, 1981
The present review provides an understanding of our current knowledge ofthe carcinogenic
effect oflow-dose radiation in man, and surveys the epidemiological studies ofhuman popula-
tions exposed to nuclear explosions and medical radiation. Discussion centers on the contribu-
tions of quantitative epidemiology to present knowledge, the reliability of the dose-incidence
data, and those relevant epidemiological studies that provide the most useful information for
risk estimation of cancer induction in man. Reference is made to dose-incidence relationships
from laboratory animal experiments where they may obtain, for problems and difficulties in
extrapolation from data obtained at high doses to low doses, and from animal data to the
human situation. The paper describes the methods ofapplication of such epidemiological data
for estimation of excess risk of radiation-induced cancer in exposed human populations and
discusses the strengths and limitations of epidemiology in guiding radiation protection
philosophy and public health policy.
INTRODUCTION
Cancer induction is the most important late somatic health effect of low-dose
ionizing radiation [1], and as the dose of radiation increases above low levels, the
risk of cancer increases in exposed human populations. It is these observations that
have been central to public concern about the potential health effects of low-level
radiation and to the task of estimating risks and establishing standards for protec-
tion ofthe health ofthe public. Epidemiological surveys on exposed human popula-
tions presently provide the scientific basis for risk estimation, but the data arehighly
uncertain in regard to the forms of the dose-response relationships for radiation-
induced cancer. This is especially the case with low-level radiation. Therefore, it has
been necessary to estimate human cancer risk at low radiation doses primarily from
observations at relatively high doses in human populations exposed to nuclear explo-
sions and medical radiation. Since it is not known whether the cancer incidence ob-
served at such high dose levels also applies to cancer induction at low dose levels,
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scientific disagreement can arise concerning the methods to be used for estimating
the carcinogenic risk from low-level radiation.
The present paper reviews the relevant epidemiological surveys on radiation car-
cinogenesis in human populations exposed to nuclear explosions or medical radia-
tion, describes the methods of application of such epidemiological data for estima-
tion of excess cancer risk in these exposed populations, and discusses the strengths
and limitations of epidemiology in guiding radiation protection philosophy and
public policy.
WHAT DO WE KNOW ABOUT RADIATION CARCINOGENESIS?
The somatic effects of concern at low doses and low dose rates are those that may
be induced by mutation in individual cells, singly or in small numbers. The most im-
portant of these is considered to be cancer induction. Current knowledge of the
carcinogenic effect of radiation in man has been reviewed to two recent reports: the
1977 Report of the United Nations Scientific Committee on the Effects of Atomic
Radiation (the 1977 UNSCEAR Report) and the 1980 Report of the National
Academy of Sciences Committee on the Biological Effects of Ionizing Radiations
(the BEIR III Report) [1,2]. The epidemiological data analyzed in these reports
derive mainly from the epidemiological studies of the Japanese atomic bomb sur-
vivors in Hiroshima and Nagasaki, from patients in England and Wales treated with
X irradiation for ankylosing spondylitis, and from several other groups ofpeople ir-
radiated from external or internal sources, either for medical reasons or through oc-
cupational exposure. Both reports emphasize that cancers of the breast, thyroid,
hemopoietic tissues, lung, and bone can be induced by radiation. Other cancers, in-
cluding cancers of the stomach, pancreas, and pharynx, lymphatic cancer, and
perhaps all tissues of the body, may also be induced by radiation. Both reports
derive risk estimates in absolute and relative terms for low-dose, low-LET1 whole
body exposure, and for leukemia, breast cancer, thyroid cancer, lung cancer, and
other cancers. These estimates derive from exposure and cancer incidence data at
high doses (most frequently greater than 50 rem)2 and at high dose rates (most fre-
quently greater than 50 rem per minute) [1,3]. There are no compelling scientific
reasons to apply these values of risk per rem derived from high doses and high dose
rates to the very low doses and low dose rates of concern in human radiation protec-
tion. In the absence of reliable human data for calculating risk estimates at very low
doses and low dose rates, neither the UNSCEAR nor BEIR Committees felt confi-
dent enough to predict the reliability of such extrapolation [1-4].
Certain general principles of radiation carcinogenesis have now emerged based on
the relatively large number ofepidemiological surveys studied. First, the younger the
exposed individual, from in utero exposure through adult life, the higher is the risk
per rem for induction of most tumors. Second, the incidence of leukemia in exposed
populations rises above normal within three to five years of exposure, and declines
within 15 to 20 years, but persists for 25 years or more after exposure. The elevated
induction rate for solid tumors becomes apparent after a latent period of 10 to 15
years following exposure in adults, and then persists for an unknown period, in
'Linear energy transfer (abbr. LET) is the average amount of energy lost per unit of particle spur-track
length. Low LET: radiation characteristic of electrons, X rays, and gamma rays. High LET: radiation
characteristic of protons, fast neutrons, and alpha particles.
2Rem is the unit of radiation dose equivalent = absorbed dose (in rads) times quality factor times
distribution factor times any other necessary modifying factors.
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some cancers for over 30 to 35 years. Few irradiated populations have, as yet, been
studied for more than 30 years. Third, whereas initially leukemia was considered the
most sensitive index of radiation carcinogenesis in man, the excess of solid tumors in
irradiated populations now exceeds that of leukemias by a significant factor [1].
And last, comparison of epidemiological data obtained from human populations ex-
posed to very different dose rates to ascertain whether there is a reduction in risk per
rem at low dose rates can not, as yet, be reliably made for different types of
neoplasms. In the case of leukemia and for radiation-induced breast cancer, the
evidence suggests that there may be little or no dose-rate effect. Fractionation of the
total dose given over several years thus far yields excess leukemia and breast cancer
risk estimates that are not significantly different from those obtained from a single
dose [1,2].
WHAT CAN WE LEARN FROM DOSE-INCIDENCE DATA IN ANIMALS
FOR EXTRAPOLATION TO MAN?
Benign and malignant tumors of almost any type or site may be induced by irradi-
ation in animals. Susceptibility to radiation carcinogenesis varies widely among
cells, tissues, organs, and organisms, depending on the influences of species dif-
ferences, genetic composition, age, sex, physiological state, and other constitutional
and environmental factors. Although all ionizing radiations are qualitatively similar
in carcinogenic activity, they vary considerably in carcinogenic effectiveness per
rad,3 depending on the dose and on the distribution of the radiation in time and
space [1-9].
The dose-incidence relationship for cancer induction has not been characterized
sufficiently over a wide range of radiation doses, dose rates, and LET to enable risk
estimation at doses below 25 rem. Wide variations occur in the shapes of the dose-
response curves for cancers of different types and for cancers of the same type. The
incidence of tumors to be expected under determined exposure conditions cannot be
predicted reliably by extrapolation from observations in animals or in man other
neoplasms or other exposure conditions [1-7].
In spite of the uncertainties in dose-incidence relationships, the following impor-
tant generalizations emerge from the extensive laboratory animal data available.
The incidence of cancer is increased by irradiation; the dose-response curve rises
with dose up to a certain dose level, above which it may reach a plateau and turn
downward with further increase in dose. In the dose range over which the incidence
increases with dose, low-LET radiations are usually more effective at high doses and
high dose rates than at low doses and low dose rates. In the same dose range, high-
LET radiations are usually more effective than low-LET radiations. For high-LET
radiations, the effectiveness is influenced less by dose and dose rate, and, in some in-
stances, protraction may increase their effectiveness. The relative biological effec-
tiveness (RBE)4 of high-LET radiations tends to increase with decreasing dose and
dose rate [1-10]. Because of wide species differences in response in laboratory ani-
mals, the cancer dose-incidence response for any species cannot provide a reliable
basis for direct quantitative risk estimates for cancer induction in man. Further-
more, variations in the shapes of dose-incidence curves for different radiation-
induced neoplasms in laboratory animals confound extrapolation from one type of
3Rad is the unit of absorbed dose of radiation = 100 ergs/g.
4Relative biological effectiveness (abbr. RBE) is defined as the ratio of the absorbed radiation dose of
high-LET radiation which produces the same biological effect as that due to a dose of low-LET radiation.
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neoplasms to another, from any one set of exposure conditions to another, or from
any one animal species to another, particularly to man.
WHAT CAN WE LEARN FROM HIGH-DOSE DATA FOR
EXTRAPOLATION TO LOW DOSES?
Because of the difficulty of obtaining reliable cancer-incidence data in laboratory
animals and in humans for low doses, for purposes of risk estimation dose-response
relationships observed at high doses must necessarily be extrapolated into the low-
dose region, where reliable human epidemiological data are not available. It is im-
possible to ascertain the true shape of the dose-effect curve at low dose levels, and
therefore the mechanism of radiation action in the low-dose levels, and therefore the
mechanism of radiation action in the low-dose region [1]. Consideration of the
spatial and temporal distribution of ionizations suggests that at very low dose levels,
the probability of interaction of ionizing events is negligible. Here, the molecular
and cellular response to radiation at very low doses must be linear with dose, ir-
respective of the shape of the dose-response curve at higher doses. It is reasonable,
as well, that the dose-response relationship for cancer incidence at very low doses
will be linear, irrespective of the complexity of the carcinogenic process.
The recent conclusion ofthe BEIR Committee [1], and those of the NCRP5 [9,11],
the ICRP6 [12], and the UNSCEAR [2] Committees, is that it is reasonable to
assume for low-LET radiation a linear-quadratic dose-response relationship for
cancer induction, with linearity predominating at the very low doses, and to assume
linear extrapolation at very low doses for the purpose of human risk estimation.
This leads to conservatism; that is, an overestimation of risk. Such extrapolations
depend on existing epidemiological data from much higher doses, which are the
lowest doses that have been estimated and reliably tested.
Because of these uncertainties and limitations in the epidemiological studies, ex-
perimental animal studies must provide essential information; however, human risk
estimation cannot be based directly on laboratory animal data. Nevertheless, the
evidence suggests that mechanisms of cancer induction in man are similar to those in
laboratory animals. It follows, therefore, that while experimental animal data are
not quantitatively or directly applicable to man, dose-response relationships in
animal studies may be considered for application to human populations exposed to
low-level radiation [5,7,9,13].
In recent years, a general hypothesis for estimation of excess cancer risk in irradi-
ated human populations, based on theoretical considerations, on extensive
laboratory animal studies, and on limited epidemiological surveys, suggests various
and complex dose-response relationships between radiation dose and observed can-
cer incidence [7,13-16]. One of the most widely considered models for cancer in-
duction by radiation, based on the available information and consistent with both
knowledge andtheory, takes thecomplexquadratic form:I(D) = (to + a,D + a2D2)
exp(-f1D - 2D2), where Iis the cancer incidence in the irradiated population at ra-
diation dose D in rad, anda0, Cal,C!2, f1, and 2 are non-negative constants (Fig. 1).
This multicomponent dose-response curve contains (1) initial upward-curving linear
and quadratic functions ofdose, which represent the process of cancer induction by
radiation, and (2) a modifying exponential function of dose, which represents the
competing effect of cell-killing at high doses. ao0 is the ordinate intercept at 0 dose,
'National Council on Radiation Protection and Measurements (abbr. NCRP)
6International Commission on Radiological Protection (abbr. ICRP)
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Dose-response model for
radiation corcinogenesis
-~~~~~~~~ g D-,2D2 FIG. 1. General dose-response model for radia-
I (D)=(aO+a,ID +aD)e(D 2D )e tion carcinogenesis based on radiobiological experi-
ments and epidemiological studies. I, cancer inci-
dence; D, radiation dose; ct., spontaneous incidence
Dose , D ( rad) of cancer in the population; a,,(1,0f2 1, 02arepositive
vuA.791-3029 coefficients.
and defines the natural incidence of cancer in the population. a,1 is the initial slope of
thle curve at 0 dose, and defines the linear component in the low-dose range. °U2 iS the
curvature near 0 dose, and defines the upward-curving quadratic function of dose.
,B1 andO2 are the slopes of the downward-curving function in the high-dose range,
and define the cell-killing function. Analysis of a number of dose-incidence curves
for cancer induction in irradiated populations, both in humans and in animals, has
demonstrated that for different radiation-induced cancers only certain of the
parameter values of these constants can be theoretically determined. Therefore, it
has become necessary to simplify the model by reducing the number of parameters
and eliminating these which would have the least effect on the form of the dose-
response relationship in the dose range of low-level radiation. Such simpler models,
in order of increasing complexity, include the linear, the pure quadratic, the
quadratic (quadratic function with a linear term in the low-dose region), and finally,
the multicomponent quadratic form with a linear term and with an exponential
modifier [1,3,7,9,13-151 (Fig. 2).
WHAT HAVE WE LEARNED FROM THE EPIDEMIOLOGICAL STUDIES
OF HUMAN POPULATIONS?
Nuclear Explosions
The most valuable human data available for evaluation of the late effects of radi-
ation come from the studies of the Atomic Bomb Casualty Commission, now in the
Radiation Effects Research Foundation,' on the Japanese A-bomb survivors in
Hiroshima and Nagasaki [171. The continuing evaluation of this population pro-
vides the most comprehensive assessment of risk estimates for the carcinogenic ef-
fect of radiation. The study population is the largest of any epidemiological survey
(over 100,000 persons), and these persons were irradiated for other than medical
reasons. The A-bomb survivors were exposed at all ages and the radiation doses
ranged from a few rads to near-lethal levels.
What are the important questions concerning the mortality experience of the
'Radiation Effects Research Foundation (abbr. RERF): Japanese foundation chartered by the Japan-
ese Welfare Ministry under an agreement between the United States and Japan.
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SHAPES OF DOSE RESPONSE CURVES
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FIG. 2. Shapes of various dose-response relationships of radiation-induced cancer in
mammalian radiobiology and in epidemiological surveys. These are derived from the gen-
eral dose-response model, and include the linear, the linear-quadratic, and the pure
quadratic dose-response curves.
atomic bomb survivors? Is radiation carcinogenesis the only important late effect
from the standpoint of mortality? Is the carcinogenic effect a general one, affecting
all tissues and histologic types? Are there reliable city differences from which
relative biological effectiveness estimates an be made? Are Nagasaki data numerous
enough to permit any close examination of the functional form of the gamma dose-
response curve for specific cancers? Can further insight be gained into the role of
age in 1945, at the time of the bomb, upon the carcinogenic effect of ionizing radi-
ation?
These studies are attempting to answer the important questions, with direct bear-
ing on estimation of the cancer risk in human populations exposed to low-dose levels.
The magnitude of risk of induction of all types of tumors in relation to dose and
time since exposure require careful evaluation. The excess risk ofleukemia following
irradiation increased with dose; after high doses it was evident within three to four
years after radiation and declined within 15 years, but persisted for 25 years or more
after exposure [17-19]. At present, there continues to be a large increase in the radi-
ation-induced cancer death rate during the ten-year period 1965 to 1974, up to 30
years after exposure. This increase is particularly evident in solid tumor induction;
there is presently no indication of a return to normal levels of the mortality rates
from these cancers. Cancers are occurring in excess in the surviving irradiated popu-
lation, due mainly to extremely long latent periods after exposure before these solid
tumors are detected. Recently, certain cancers not previously thought to be
radiation-induced are appearing in excess in the irradiated population. And finally,
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of the cancer death rate-is essential information for projecting the long-term car-
cinogenic effects in persons irradiated as children or young adults.
Present cancer risk estimates predicted to occur as a result of low-dose exposure
of human populations to radiation rely on assumptions about these important ques-
tions and on assumptions on the method of extrapolation from human data obtained
at high doses to low doses. At the present time, estimated excess cancer rates are de-
rived from observations on Japanese A-bomb survivors of Hiroshima and Nagasaki
averaged over the period 1960 to 1974. The excess cancer death rate of these sur-
vivors could rise, remain the same, or decrease during the coming years. For
leukemia induction in the Nagasaki survivors, the Life Span Study (LSS)8 death cer-
tificate data appear consistent with a quadratic dose-incidence relationship (Fig. 3).
The shape of the Nagasaki curve is considered a strong determinant ofthe value for
the RBE for neutrons derived from the Hiroshima (neutron-rich) and Nagasaki
(neutron-deficient) exposure [17,19].
The leukemia dose-response curves in the LSS sample and the Leukemia Registry
in the two cities are compared in Fig. 3 [17]. An apparent curvilinear relationship in
the low-dose region results from the sparsity of leukemia cases in the Nagasaki LSS
sample below 100 rads kerma; this relationship is much less marked when all the
Registry cases are used. The leukemia incidence in the Nagasaki LSS sample is less
than in the Hiroshima survivors at all doses except in the 0-9 rad group. This in-
creased incidence in the Hiroshima survivors implies a greater RBE for neutrons for
leukemia induction than gamma rays, and the neutron RBE is greater than one. The
curvilinearity in the Nagasaki sample indicates that the neutron RBE increases as the
"Life Span Study (abbr. LSS) of the Japanese atomic-bomb survivors; sample consists of 109,000 per-
sons, of whom 82,000 were exposed to the bombs, mostly at low doses.
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FIG. 3. Left: Relative risk of radiation-induced leukemia in Japanese atomic
bomb survivors in Hiroshima plotted against T65 dose (kerma) [17]. Compari-
son ofthe Life Span Study (LSS) death certificate data (solidline) and the total
Leukemia Registry (dashed line) data. The Hiroshima atomic bomb contained
a relatively large fraction (approximately 19 percent) of neutrons. Right:
Relationship of radiation-induced leukemia in Japanese atomic bomb sur-
vivors in Nagasaki plotted against T65 dose (kerma [17]. Comparison of the
LSS death certificate data (solid line) and the total Leukemia Registry data
(dashed line). The Nagasaki atomic bomb contained a relatively small fraction
(approximately one percent) of neutrons.
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dose diminishes [18,191. This is believed to be due to greater repair capacity of ef-
fects oflow-dose, low-LET gamma radiation, rather than increased damage per unit
of high-LET neutron radiation [18].
Another population that received irradiation as aresult ofa nuclear explosion was
the Marshall Islanders, who were exposed to fallout from an H-bomb test explosion
in 1954 [20]. In this population, the main health effects came from short-lived fis-
sion iodine radioisotopes; this has contributed to our knowledge of risk estimates
for thyroid cancer following irradiation. However, the data on the Marshallese are
difficult to analyze, primarily because their radiation exposures were to a mixture of
high dose rate external and internal gamma photons, as well as to beta radiation.
Medical Radiation Exposures
The initial reports of Stewart and her colleagues [21] described an excess of
leukemia and all other cancers among children irradiated in utero when their
mothers received diagnostic pelvic X irradiation during the pregnancy. The two larg-
est studies [22,23] indicated that diagnostic pelvic X-ray examinations during preg-
nancy resulted in an increase ofapproximately 50 percent in cancer mortality among
the children during the first ten years of life. Because the doses involved an average
dose to the fetus of about 1 rad, these surveys are extremely important to radiation
protection of the general population. However, failure to confirm these results in
the children of the Japanese women who were exposed to atom-bomb radiation in
Hiroshima and Nagasaki, and the inability to reproduce the result in laboratory
animals, has led to the questioning of whether radiation alone is the etiologic agent
in the human surveys [38].
Several other human populations exposed to diagnostic X-rays have been studied.
Multiple diagnostic exposure to adult males appears to be associated with the in-
creased risk of developing leukemia [23]. The risk estimates for leukemia induction
from this study are similar to those obtained from data at high doses of radiation.
Studies that increase the precision of risk estimates for induction of breast cancer
are those of a follow-up of pulmonary tuberculosis patients for whom the treatment
of choice prior to 1950 was artificial pneumothorax, which was associated with
repeated fluoroscopic exposures. The initial surveys of female patients treated in a
Nova Scotia sanatorium between 1940 and 1949 [24,25] indicated that despite the
uncertainty ofthe radiation dose estimates and the extreme fractionation ofthe total
dose, the risk per rad for breast cancer induction is large and very similar to single-
exposure studies, in which high doses were absorbed by the breast tissue [17]. These
data appear consistent with a linear dose-incidence relationship [16] (Fig. 4).
Important information has been obtained from persons who have been irradiated
either externally or by internal emitters for therapeutic reasons. Court-Brown and
Doll [26] analyzed the data on leukemia and all other cancers in over 14,000 patients
with ankylosing spondylitis who received external irradiation from 1935 to 1954 in
the United Kingdom. The leukemia data in these patients are in reasonably good
agreement with those from the Japanese A-bomb survivors. Another study of pa-
tients irradiated for ankylosing spondylitis and other diseases is that of Spiess and
Mays [27,28]; here, the patients received intravenous injections of the bone-seeking
alpha-emitter radium-224. The evidence indicates that the younger patients are
slightly more susceptible to the induction of bone sarcomas for equal protraction
periods and that the data are consistent with a quadratic dose-incidence relationship.
Irradiation for medical reasons often introduces uncertainties into the interpreta-
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FIG. 4. Incidence of excess breast cancer in irradiated women plotted against radiation
dose. Upper left: Japanese atomic bomb survivors. Upper right: women fluoroscoped in
Massachusetts tuberculosis sanatorium. Lower left: postpartum mastititis patients.
Lowerright: women fluoroscoped in Nova Scotia tuberculosis sanatorium. The excess in-
cidence is expressed in terms of women-years (WY) at risk.
tion of data from patients, particularly the potential influence of the disease for
which the patients were treated. Furthermore, analysis of the dose-incidence rela-
tionships for carcinogenesis by internal emitters is complicated by several sources of
uncertainty relating to variations in the spatial and temporal distribution of the
dose, which are, in turn, dependent on the uptake, disposition, metabolism, and
elimination ofthe radionuclide [1-8,29]. In most patients, the initial dose, dose rate,
and patterns of radionuclide excretion are unknown. Furthermore, the radioactivity
in these individuals may be deposited nonuniformly in bone, and concentrated in
hot spots where the dose at the center is very much higher than that in surrounding
bone [29].
Occupational Exposures
Valuable epidemiological surveys exist on populations of workers exposed as a
result of their occupations; these include, for example, uranium and fluorspar
miners, radiologists, radium-dial painters, and workers in the processing of
plutonium [1-4]. Some of these groups have been followed for many years. Impor-
tant data are available in spite of the complexities of long-term epidemiological
studies, such as mobility of populations, nonuniformity of occupational histories,
0
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and inadequacy of dosimetry. These studies will be discussed at length by my col-
leagues in this symposium.
High Natural Background Areas
There are populations exposed to lifetime doses of very high natural background
radiation; two are those living in the monazite sands regions of Brazil and India,
where they have resided for many generations. Attempts to obtain reliable epidemi-
ological data from these populations have failed due primarily to the complications
of collecting human epidemiological data and further confounded by local cultural,
religious, and political practices.
Natural background radiation may vary from one geographic region to the next
[1]. Attempts to correlate background dose with human epidemiological data are
confounded by errors and lack ofuniformity in the dosimetric estimates ofradiation
levels, and by varying quality ofvital statistics information among the various com-
munities, states, regions, and countries [1-4]. The sources of bias introduced by
these factors have thus far been greater than differences that are likely to be of any
value.
WHAT ARE THE SOURCES OF EPIDEMIOLOGICAL DATA
FOR THE ESTIMATION OF EXCESS CANCER RISK
IN EXPOSED HUMAN POPULATIONS?
The tissues and organs about which we have the most reliable epidemiological
data on radiation-induced cancer in man, obtained from a variety of sources from
which corroborative risk coefficients have been estimated, include the bone marrow,
the thyroid, the breast, and the lung [1,2]. The data on bone and the digestive organs
are, at best, preliminary, and do not approach the precision of the others. For
several of these tissues and organs, risk estimates are obtained from very different
epidemiological surveys, some followed for over 30 years, and with adequate control
groups. There is good agreement when one considers the lack of precision inherent
in the statistical analyses of the case-finding and cohort study populations, variabil-
ity in ascertainment and clinical periods of observation, age, sex, and racial struc-
ture, different radiation dose levels, and constraints on data from control groups.
The most reliable data have been those of the risk of leukemia, which come from
the Japanese atomic bomb survivors [17,18,38], the ankylosing spondylitis patients
treated with X-ray therapy in England and Wales [26], the patients treated with
radiotherapy for benign uterine bleeding [30], the patients treated with radiation for
ringworm ofthe scalp [31], and the early radiologists [32,33]. There is evidence ofan
age dependence and a dose dependence, a relatively short latent period of a matter
of a few years, and a relatively short period ofexpression, some ten years. This can-
cer is uniformly fatal.
The data on thyroid cancer are more complex. These surveys include the large
series of children treated with radiation to the neck and mediastinum for enlarged
thymus [34], children treated to the scalp for tinea capitis [31], and the Japanese
atomic bomb survivors [17] and Marshall Islanders [20] exposed to nuclear explo-
sions. Here, there is an age dependence and sex dependence-children and females
appear more sensitive. Although the induction rate is high, the latent period is
relatively short, and it is probable that no increased risk will be found in future
follow-up of these study populations. In addition, most tumors are either thyroid
nodules or benign or treatable tumors, and only a few are fatal.
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Much information has become available on radiation-induced breast cancer in
women [35,39]. The surveys include primarily women with tuberculosis who re-
ceived frequent fluoroscopic examinations for artificial pneumothorax [25], post-
partum mastitis patients treated with radiotherapy [36], and the Japanese atomic
bomb survivors in Hiroshima and Nagasaki [17]. Here, there is an age dependence
and dose dependence, as well as a sex dependence. The latent period is long; 20 to 30
years. Perhaps about half of these neoplasms are fatal.
Another relatively sensitive tissue, and a complex one as regards radiation dose in-
volving parameters of the special physical and biological characteristics ofthe radia-
tion quality, is the epithelial tissue of the bronchus and lung. These surveys include
the Japanese atomic bomb survivors [17], the uranium miners in the United States
and Canada [37], and the ankylosing spondylitis patients in England and Wales [26].
There is some evidence of age dependence from the Japanese experience, and a rela-
tively long latent period. This cancer is uniformly fatal.
The risk of radiation-induced bone sarcoma, based primarily on surveys of the
radium and thorium patients who had received the radioactive substances for
medical treatment, or persons who ingested these materials in the course oftheir oc-
cupations [28], is low. For all other tumors arising in various organs and tissues of
the body, values are extremely crude and estimates are, at best, preliminary.
WHAT CAN WE CONCLUDE?
Of various somatic effects that might be produced by ionzing radiation at low
levels of dose and dose rate, cancer induction is presently considered to be the most
important potential hazard to health in exposed human populations. Studies of ir-
radiated human populations indicate a dose-dependent increase in the incidence of
most types of cancer. The dose-response relationships for these cancers are consis-
tent with a range of linear, linear-quadratic, and quadratic relationships between
cancer incidence and dose. The data on the influence of dose rate in man are limited
and at present fail to indicate a reduction of risk per rad with decreasing dose rate.
The available dose-incidence data suggest an age dependency and a sex dependency;
the overall susceptibility appears higher in children than in adults.
All tissues of the body are susceptible to cancer induction by radiation. The
epidemiological data are inadequate to define the dose-response relationships at
doses below 25 to 50 rem. Data for high-LET radiation are only fragmentary; these
suggest a high RBE with little change in effectiveness per rad with decreasing dose
and dose rate. Data for low-LET radiation, on the other hand, generally show a
decrease in the effectiveness per rad with decreasing dose and dose rate.
Numerical estimation of the risk of radiation-induced cancer in man must neces-
sarily be based primarily on human dose-incidence data. However, risk estimation at
very low doses and low dose rates at present must also necessarily depend on extra-
polation from observations at higher doses and higher dose rates, based on assump-
tions about the dose-incidence relationships and the mechanisms of carcinogenesis.
Improvements in our knowledge of the carcinogenic effectiveness of ionizing radia-
tion will depend on the elucidation of mechanisms of carcinogenesis, especially at
the very earliest stages of malignant transformation, and on the provision of em-
pirical dose-incidence data for low doses both in human populations and in
laboratory animals experiments, insofar as this is possible.
And finally, we must conclude that the estimation ofthe carcinogenic risk oflow-
dose, low-LET radiation is subject to numerous uncertainties. The greatest of these
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concerns is the shape ofthe dose-response curve. Others include the length ofthe la-
tent period, the RBE for fast neutrons and alpha radiation relative to gamma and X
radiation, the period during which the radiation risk is expressed, the model used in
projecting risk beyond the period ofobservation, the effect ofdose rate or dose frac-
tionation, and the influence of differences in the natural incidence of specific types
of cancer. In addition, uncertainties are introduced by the biological risk charac-
teristics of humans; for example, the effect of age at irradiation, the influence of
any disease for which the radiation was given therapeutically, and the influence of
length of observation or follow-up ofthe study populations. The collective influence
of these uncertainties is such as to deny great credibility to any estimates of human
cancer risk that can be made for low-dose, low-LET radiation. Nevertheless, despite
all the uncertainties I have chosen to discuss, there is greater knowledge of the risks
of radiation than of any other potentially hazardous physical or chemical agent in
the environment.
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